Related Experiment Video
Updated: Jun 26, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor
1Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702-1201.
Abstract:
EGF receptors are found on the surface of most cells, usually with high and low binding affinities. To investigate functional relationships between EGF (EGF-like growth factors) and oncogenes we have characterized the expression of the epidermal growth factor receptor (EGFr) in H-Ras, v-Myc, and H-Ras-v-Myc transformed Balb/3T3 cells. H-Ras cells show a marked decrease in the number of EGFr molecules per cell compared to parental cells. v-Myc and H-Ras-v-Myc transformed cells express an intermediate level of receptors. The majority of the EGF receptors on the parental and oncogene transformed cells bind EGF with low affinity and this low affinity receptor is down-regulated by oncogene transformation. v-Myc expression, in the H-Ras-v-Myc transformed cells, abrogates the receptor down-regulation seen with H-Ras transformation. The mechanism of abrogation is not a result of a change in the p21-Ras concentration in the H-Ras-v-Myc transformed cells. In addition, the mitogenic response to EGF was examined. H-Ras and H-Ras-v-Myc transformed cells do not respond to EGF mitogenically. In contrast, EGF stimulates DNA synthesis in parental cells and v-Myc transfected cells; this result suggests that growth promoting signals from the EGF receptor may not be required in H-Ras transformed cells.
Insights
Oncogene transformation alters epidermal growth factor receptor (EGFr) expression and function. While H-Ras transformation reduces EGFr and mitogenic response, v-Myc counteracts this down-regulation, suggesting altered growth signaling pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Epidermal growth factor receptors (EGFr) are crucial cell surface proteins involved in growth regulation.
- Oncogenes, such as H-Ras and v-Myc, can alter cellular signaling pathways.
- Understanding the interplay between oncogenes and EGFr is vital for cancer research.
Purpose of the Study:
- To investigate the functional relationship between oncogenes (H-Ras, v-Myc) and epidermal growth factor receptor (EGFr) expression and signaling.
- To characterize EGFr expression and EGF binding affinity in oncogene-transformed cells.
- To examine the mitogenic response to EGF in parental and transformed cells.
Main Methods:
- Characterization of EGFr expression levels in Balb/3T3 cells transformed with H-Ras, v-Myc, or both.
- Assessment of EGF binding affinity (high and low) to EGFr on parental and transformed cells.
- Evaluation of the mitogenic response to EGF, including DNA synthesis, in different cell lines.
Main Results:
- H-Ras transformation significantly decreased the number of EGFr molecules per cell.
- v-Myc and H-Ras-v-Myc transformed cells exhibited intermediate EGFr levels.
- Low-affinity EGFr was down-regulated by oncogene transformation, but v-Myc expression abrogated this effect in H-Ras-v-Myc cells.
- H-Ras and H-Ras-v-Myc transformed cells showed no mitogenic response to EGF, unlike parental and v-Myc cells.
Conclusions:
- Oncogene transformation profoundly impacts EGFr expression and EGF signaling.
- v-Myc can override the down-regulatory effects of H-Ras on EGFr.
- Growth-promoting signals from EGFr may not be essential for proliferation in H-Ras transformed cells, indicating alternative survival pathways.
Related Concept Videos
Mitogens and the Cell Cycle
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades

